| STRENGTH Expansion (NCT04520867) | University of Colorado, Denver | 2020-08-06 |
| A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies (NCT04440943) | Celldex Therapeutics | 2020-08-04 |
| 99m Tc-3PRGD2 SPECT/CT Imaging in the Diagnosis of Lymph Node Metastasis of Esophageal Carcinoma (NCT04504565) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2020-08-01 |
| A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors (NCT04424641) | Genmab | 2020-07-15 |
| The Microbiome of Oesophageal Squamous Cell Carcinoma (NCT04425122) | Chinese University of Hong Kong | 2020-07-01 |
| Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer (NCT04426955) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-30 |
| Volume Outcome Relationships and Effects (NCT06343597) | Methodist Health System | 2020-06-15 |
| Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor (NCT04545632) | Boryung Pharmaceutical Co., Ltd | 2020-06-10 |
| A Biomarker-driven Therapeutic Strategy for Esophageal Cancer Chemoradiotherapy in Patients With Resectable Adenocarcinoma of the ESophagus and Esophagogastric Junction (NCT04269083) | Azienda Ospedaliera Universitaria Integrata Verona | 2020-05-24 |
| Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging (NCT04400292) | Memorial Sloan Kettering Cancer Center | 2020-05-20 |
| A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering (NCT04426669) | Intima Bioscience, Inc. | 2020-05-15 |
| Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI (NCT04359732) | IRCCS San Raffaele | 2020-05-08 |
| Spanish Registry of Esophagogastric Cancer (NCT04958720) | Fundación Sociedad Española de Oncologia Médica | 2020-04-27 |
| A Study of Camrelizumab As Consolidation Therapy After Radical Concurrent Chemoradiotherapy In Locally Advanced ESCC (NCT04286958) | Hebei Medical University Fourth Hospital | 2020-04-22 |
| Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma (NCT04280822) | Henan Cancer Hospital | 2020-04-21 |
| A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies (NCT04316078) | Sheba Medical Center | 2020-03-15 |
| Prehabilitation on Fitness, Surgical Outcomes and Mitochondria Functionality in Patients With Esophageal Cancer (NCT04673968) | Chang Gung Memorial Hospital | 2020-02-25 |
| Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients (NCT04269369) | Jessa Hospital | 2020-02-18 |
| Cryotherapy for Locally Advanced Esophageal Cancer (NCT04248582) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2020-02-11 |
| Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer (NCT04576858) | Rigshospitalet, Denmark | 2020-02-03 |
| Serial MRI Scans During Radiation Therapy (NCT04188535) | Dana-Farber Cancer Institute | 2020-01-15 |
| Minimizing Pathologic Aspiration in Patients Undergoing Esophageal and Lung Resections for Cancer (NCT04251312) | University of Mississippi Medical Center | 2020-01-14 |
| LITT and Pembrolizumab in Recurrent Brain Metastasis (NCT04187872) | University of Florida | 2020-01-10 |
| Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients (NCT04896242) | Pontificia Universidad Catolica de Chile | 2020-01-09 |
| Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19 (NCT07416825) | Institute of Oncology Ljubljana | 2020-01-01 |
| A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy (NCT04217239) | The Second Hospital of Shandong University | 2020-01-01 |
| Dose Escalated Adaptive RadioTherapy in Definitive Chemo-radiotherapy for Esophageal Cancer (NCT04086901) | University of Aarhus | 2020-01-01 |
| Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery (NCT04189393) | Radboud University Medical Center | 2020-01-01 |
| Real-world Study on Comprehensive Treatment of Esophageal Cancer Based on Precision Radiotherapy (NCT05543057) | Zefen Xiao | 2020-01-01 |
| A Phase II Exploratory Clinical Trial of Multiple Drug Combinations in the Treatment of Advanced Esophageal Squamous Cell Carcinoma (NCT03736863) | The First Affiliated Hospital of Zhengzhou University | 2019-12-05 |
| Preemptive Endoluminal Negative Pressure in Minimally Invasive Transthoracic Esophagectomy (NCT04162860) | University of Zurich | 2019-12-04 |
| Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer (NCT03818997) | European Organisation for Research and Treatment of Cancer - EORTC | 2019-12-01 |
| Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted Analysis (NCT07549269) | Sichuan University | 2019-12-01 |
| Temporal Variation in Exhaled Volatile Organic Compounds in Esophageal Cancer Patients (NCT06453993) | Benaroya Research Institute | 2019-12-01 |
| Applying PET/MR in Oncology - a Prospective Project (NCT04158414) | Tel-Aviv Sourasky Medical Center | 2019-11-28 |
| Chemoradiotherapy for Advanced Esophageal Cancer (NCT02297217) | AHS Cancer Control Alberta | 2019-11-21 |
| Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors (NCT04116320) | Craig L Slingluff, Jr | 2019-11-21 |
| A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer (NCT04207918) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2019-11-14 |
| A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer (NCT04161781) | Memorial Sloan Kettering Cancer Center | 2019-11-12 |
| Laparoscopic Ischemic Conditioning Prior to Esophagectomy (NCT03896399) | UMC Utrecht | 2019-11-11 |
| Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer (NCT04046575) | Washington University School of Medicine | 2019-11-07 |
| DRIHNC - Dehydration Reduction in Head & Neck Cancer (NCT03799380) | Case Comprehensive Cancer Center | 2019-11-05 |
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer (NCT03908671) | Stemirna Therapeutics | 2019-10-18 |
| Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy (NCT04068896) | NGM Biopharmaceuticals, Inc | 2019-10-16 |
| Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. (NCT03983954) | NeoTX Therapeutics Ltd. | 2019-10-10 |
| Chemoradiotherapy in Unresectable Esophageal Cancer (NCT04278287) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2019-10-01 |
| Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent) (NCT03962179) | University Hospital of Cologne | 2019-09-22 |
| Study to Evaluate the Safety of Nanoxel M Inj. (NCT04066335) | Samyang Biopharmaceuticals Corporation | 2019-09-18 |
| Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers (NCT04077372) | Stanford University | 2019-09-16 |
| Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma (NCT04135664) | Shanghai Chest Hospital | 2019-09-01 |
| ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) (NCT04044859) | USWM CT, LLC | 2019-08-20 |
| The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer Patients (NCT05855278) | Chang Gung Memorial Hospital | 2019-08-13 |
| Effect of Preoperative Immunonutrition in Upper Digestive Tract (NCT04027088) | Complexo Hospitalario Universitario de A Coruña | 2019-08-10 |
| Pre-Surgery If Needed for Oesophageal Cancer (NCT03937362) | Shanghai Chest Hospital | 2019-08-08 |
| First-in-human Study of S-588210 (S-488210+S-488211) (NCT04316689) | Shionogi | 2019-07-30 |
| A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma (NCT03840967) | Shadia Jalal, MD | 2019-07-09 |
| Oesophagectomy and Chest Wall and Respiratory Function (NCT03835273) | Imperial College London | 2019-05-29 |
| Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors (NCT04354064) | Washington University School of Medicine | 2019-05-29 |
| Predicting Disease Progression and/or Recurrence in Cancer (NCT04776837) | Massachusetts General Hospital | 2019-05-15 |
| The Efficacy of Immunodetection Point Inhibitors for Advanced Esophageal Cancer (NCT04074447) | Sun Yat-sen University | 2019-05-01 |
| Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer (NCT03764553) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2019-05-01 |
| SOX-based CRT for Esophageal Cancer. (NCT03991104) | Zhejiang Provincial People's Hospital | 2019-05-01 |
| Simultaneous Integrated Boost for Mediastinal Lymph Node Recurrence After Radical Surgery of Esophageal Cancer (NCT03990532) | Ruijin Hospital | 2019-04-30 |
| IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients (NCT03910634) | Sun Yat-sen University | 2019-04-09 |
| TreatmENT of AnastomotiC Leakage After Esophagectomy (NCT03829098) | Radboud University Medical Center | 2019-04-01 |
| Perioperative Nutritional Support in Esophageal Cancer Patients (NCT04190121) | THEODOROU DIMITRIOS | 2019-03-26 |
| Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and Survival (NCT03676478) | University Hospital, Gasthuisberg | 2019-03-25 |
| Treatment Outcomes of Esophageal Cancer (NCT05177393) | University of California, San Francisco | 2019-02-28 |
| The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (NCT04075305) | UMC Utrecht | 2019-02-01 |
| Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer (NCT04014465) | Chinese Academy of Medical Sciences | 2019-02-01 |
| A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies (NCT03829501) | Kymab Limited | 2019-01-28 |
| The Efficacy of Postoperative Application of HFNC at Acute Phase for Minimally Invasive Esophagectomy Surgery Patients (NCT03816748) | National Taiwan University Hospital | 2019-01-01 |
| Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients (NCT03787056) | Hospices Civils de Lyon | 2018-12-04 |
| A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China (NCT03565003) | Jacobio Pharmaceuticals Co., Ltd. | 2018-11-20 |
| A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors (NCT03734926) | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 2018-11-13 |
| Study of ADCT-301 in Patients With Selected Advanced Solid Tumors (NCT03621982) | ADC Therapeutics S.A. | 2018-11-09 |
| Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer (NCT03649945) | First Affiliated Hospital of Guangxi Medical University | 2018-11-01 |
| Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients (NCT03731442) | Chinese Academy of Medical Sciences | 2018-11-01 |
| Robotic Versus Thoracolaparoscopic Esophagectomy for Esophageal Cancer (NCT03727126) | GEM Hospital & Research Center | 2018-11-01 |
| Fluorescence Endoscopy of Esophageal Carcinoma (NCT03558724) | University Medical Center Groningen | 2018-10-29 |
| Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer (NCT03712774) | Ludwig-Maximilians - University of Munich | 2018-10-12 |
| Design of the EFECTS Trial (NCT02017366) | University Hospital, Gasthuisberg | 2018-10-01 |
| PAN-study: Pan-Cancer Early Detection Study (PAN) (NCT03756597) | Owlstone Ltd | 2018-09-26 |
| A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies (NCT03652077) | Incyte Corporation | 2018-09-24 |
| Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC (NCT03671265) | Tianjin Medical University Cancer Institute and Hospital | 2018-09-17 |
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors (NCT03662204) | Exact Sciences Corporation | 2018-08-23 |
| The Comparison of Single and Multi-incision MIE for Esophageal Cancer (NCT03646110) | National Taiwan University Hospital | 2018-08-17 |
| Perioperative Perfusion Measurement - a Feasibility and Usability Study (NCT03671642) | Rigshospitalet, Denmark | 2018-08-08 |
| HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery (NCT03642093) | Siobhan Trotter | 2018-08-01 |
| High Dose PET/CT-guided Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer (NCT03936179) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2018-08-01 |
| PET in Guiding Cervical Lymphadenectomy (ECTOP-2003) (NCT03244566) | Fudan University | 2018-06-26 |
| A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies (NCT03538028) | Incyte Biosciences International Sàrl | 2018-06-18 |
| PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL (NCT03543813) | CytomX Therapeutics | 2018-06-15 |
| Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy (NCT03515356) | University of Michigan Rogel Cancer Center | 2018-06-13 |
| VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma (NCT03556228) | VM Oncology, LLC | 2018-06-08 |
| Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos (NCT03668418) | University of Pisa | 2018-06-01 |
| Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage for Esophageal or Junctional Carcinoma. (NCT03529266) | Sun Yat-sen University | 2018-06-01 |
| Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac (NCT04172753) | University Hospital Tuebingen | 2018-05-09 |
| A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors (NCT03526835) | Merus B.V. | 2018-05-02 |
| Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC) (NCT03544736) | Oslo University Hospital | 2018-04-26 |